Published in World J Gastroenterol on April 07, 2008
Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression. J Leukoc Biol (2011) 1.48
Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav Immun (2010) 0.97
Therapeutic effects of four strains of probiotics on experimental colitis in mice. World J Gastroenterol (2009) 0.97
CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis. Am J Pathol (2010) 0.95
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments. Mediators Inflamm (2015) 0.89
Hydrolysate from eggshell membrane ameliorates intestinal inflammation in mice. Int J Mol Sci (2014) 0.82
Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis. World J Gastroenterol (2011) 0.82
Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice. J Transl Med (2014) 0.81
Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol (2012) 0.78
Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis. Clin Rheumatol (2010) 0.75
Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease. Evid Based Complement Alternat Med (2017) 0.75
Nutritional stimulation of the autonomic nervous system. World J Gastroenterol (2011) 0.75
Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice. Stem Cell Res Ther (2015) 0.75
The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.75
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Inflammatory bowel disease. N Engl J Med (2002) 21.17
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78
Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr (1995) 13.30
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest (2006) 11.89
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (2007) 7.81
Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med (2006) 7.76
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med (2006) 5.76
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun (2000) 5.65
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet (2005) 5.35
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet (2006) 5.10
The IL-23/IL-17 axis in inflammation. J Clin Invest (2006) 4.32
Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut (2000) 4.32
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol (2006) 4.04
Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med (2000) 2.93
Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology (2005) 2.85
New genes in inflammatory bowel disease: lessons for complex diseases? Lancet (2006) 2.72
Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol (2001) 2.62
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology (1995) 2.38
Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology (1997) 2.37
Cytokines in inflammatory bowel disease. World J Surg (1998) 2.30
Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci (2007) 2.28
Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology (2005) 2.25
Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol (2003) 2.21
Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci (1996) 2.15
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 2.14
Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol (1998) 2.01
Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology (2004) 1.97
Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol (2001) 1.79
Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids (2006) 1.76
Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology (2001) 1.76
The mechanism of action of probiotics. Curr Opin Gastroenterol (2007) 1.70
The immune response in inflammatory bowel disease. Am J Gastroenterol (2007) 1.67
IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol (2002) 1.64
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology (2007) 1.64
Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest (1997) 1.59
Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol (2004) 1.52
Intestinal barrier function. Curr Opin Clin Nutr Metab Care (2002) 1.51
Role of reactive oxygen metabolites in experimental colitis. Gut (1990) 1.51
Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res (2005) 1.51
Oxygen radicals in ulcerative colitis. Free Radic Biol Med (1992) 1.50
Defects in mucosal immunity leading to Crohn's disease. Immunol Rev (2005) 1.48
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet (2007) 1.48
Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut (2003) 1.38
Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer. Gastroenterology (2002) 1.35
Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut (2005) 1.27
Dendritic cells: the commanders-in-chief of mucosal immune defenses. Curr Opin Gastroenterol (2006) 1.27
Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut (1998) 1.24
Cytokine therapy for Crohn's disease: advances in translational research. Annu Rev Med (2007) 1.22
Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology (1991) 1.22
Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol (2002) 1.17
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment Pharmacol Ther (2006) 1.14
Intestinal epithelial cell regulation of mucosal inflammation. Immunol Res (2004) 1.08
Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut (2001) 1.04
N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc (2002) 1.03
The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2002) 1.02
Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci (2000) 1.02
Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest (1997) 1.02
Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr (2002) 1.01
Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced? J Smooth Muscle Res (2007) 0.97
The gut as an organ of immunology. Int J Colorectal Dis (2002) 0.97
Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut (2004) 0.97
Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid. Dig Dis Sci (1998) 0.97
Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol (2006) 0.96
Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease. Inflamm Bowel Dis (2004) 0.95
Differential responses of intrinsic and extrinsic innervation of smooth muscle cells in rat colitis. Exp Neurol (2005) 0.94
Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol (2004) 0.92
Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis (2003) 0.91
Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study. Dig Dis Sci (1999) 0.90
Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation. Clin Nutr (1997) 0.89
A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr (1998) 0.88
Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol (2005) 0.87
Nutritional factors in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1998) 0.86
Interaction between nutrients, pro-inflammatory cytokines and inflammation. Clin Sci (Lond) (1996) 0.86
Selective loss of NGF-sensitive neurons following experimental colitis. Exp Neurol (2005) 0.85
The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol (2005) 0.84
Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol (2002) 0.84
Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol (1996) 0.83
Infliximab use in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2007) 0.83
The role of probiotics in inflammatory bowel disease. Dig Dis Sci (2007) 0.82
Genetics of inflammatory bowel disease: current status and future directions. Can J Gastroenterol (2006) 0.82
CD4+ intestinal mucosal lymphocytes in the pathogenesis of Crohn's disease. J Gastroenterol (1995) 0.81
Effects of morin on an experimental model of acute colitis in rats. Pharmacology (1998) 0.81
Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. Br J Pharmacol (2000) 0.79
The use of tacrolimus in the treatment of inflammatory bowel disease. Expert Opin Drug Saf (2007) 0.78
Epithelial cell antigen presentation. Curr Opin Gastroenterol (2000) 0.77
Induction and modulation of gastrointestinal inflammation. Immunol Today (1998) 0.76
Events at the host-microbial interface of the gastrointestinal tract. I. Adaptation to a microbial world: role of epithelial bactericidal/permeability-increasing protein. Am J Physiol Gastrointest Liver Physiol (2005) 0.76
Human cryptosporidiosis: spectrum of disease. Report of six cases and review of the literature. Arch Intern Med (1983) 2.10
Bacteremia caused by Campylobacter-like organisms in two male homosexuals. Ann Intern Med (1984) 2.07
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax (2009) 1.65
Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol (1986) 1.50
Usefulness of flow volume loops in emergency center and ICU settings. Chest (1997) 1.43
Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplant (1999) 1.41
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG. Science (1971) 1.33
Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol (1998) 1.31
Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol (1971) 1.29
Immunological characterization of homosexual males. Cancer Res (1983) 1.29
Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan. Transplantation (1972) 1.18
Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology (2001) 1.17
AIDS exacerbates psoriasis. N Engl J Med (1985) 1.15
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res (1985) 1.10
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol (1985) 1.07
Primitive leiomyosarcoma of the breast: case report and review of the literature. Breast (2004) 1.04
Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sarcoma. N Engl J Med (1983) 1.03
20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am J Physiol (1995) 1.02
Delayed onset right-sided diaphragmatic hernia secondary to group B streptococcal infection. Pediatr Infect Dis J (1991) 1.02
Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. Surgery (1971) 0.98
Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol (1987) 0.97
Cryptosporidial cholecystitis. N Engl J Med (1983) 0.97
Disseminated infection due to Mycobacterium avium-intracellulare in a homosexual man with Kaposi's sarcoma. J Infect Dis (1982) 0.96
Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style. Cancer Res (1984) 0.96
Effect of dietary nucleotides on small intestinal repair after diarrhoea. Histological and ultrastructural changes. Gut (1994) 0.94
Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice. J Natl Cancer Inst (1971) 0.94
Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol (1997) 0.93
Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation? Transplant Proc (2003) 0.92
Nonbacterial thrombotic endocarditis in a male homosexual with Kaposi's sarcoma. Arch Intern Med (1983) 0.90
Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr (1994) 0.90
Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice. Cancer Res (1972) 0.90
Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy. Natl Cancer Inst Monogr (1973) 0.88
Recurrent papillary thyroid cancer: analysis of prognostic factors including the histological variant. Eur J Surg (2001) 0.88
The cerebral hemodynamic response to asphyxia and hypoxia in the near-term fetal sheep as measured by near infrared spectroscopy. Pediatr Res (1998) 0.87
Pharmacokinetic study of partially pure gamma-interferon in cancer patients. Cancer Res (1984) 0.86
Hepatic artery complications in a series of 300 orthotopic liver transplants. Transplant Proc (2000) 0.86
Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples. Anal Cell Pathol (1998) 0.85
Mechanism of neuraminidase induced antigen "unmasking". Surg Forum (1970) 0.85
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med (1994) 0.85
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. JAMA (1987) 0.84
Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux. Ann Surg (2001) 0.84
Spectrum of central nervous system complications in homosexual men with acquired immune deficiency syndrome. J Infect Dis (1983) 0.83
Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon. J Clin Oncol (1985) 0.83
Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A. Cancer (1974) 0.83
Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine. Dig Dis Sci (1997) 0.82
Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry (1997) 0.82
Superficial phaeohyphomycosis of the scrotum in a patient with the acquired immunodeficiency syndrome. Arch Dermatol (1987) 0.82
Pharmacokinetics of liposomal nystatin in patients with human immunodeficiency virus infection. J Infect Dis (1993) 0.81
Combined use of BCG and neuraminidase in experimental tumor immunotherapy. Surg Forum (1971) 0.81
Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res (2000) 0.81
Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. II. Intratumor injections of neuraminidase. Surgery (1972) 0.81
Influence of dietary nucleotides on liver structural recovery and hepatocyte binuclearity in cirrhosis induced by thioacetamide. Gut (1996) 0.80
Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells. J Natl Cancer Inst (1973) 0.80
Coexpression of T- and B-markers in a lymphoproliferative disorder. Scand J Haematol (1986) 0.80
Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells. Ann Surg (1972) 0.80
Suppressor cell activity among the peripheral blood leukocytes of selected homosexual subjects. Cancer Res (1983) 0.80
Definitive treatment for persistent hypoparathyroidism in a kidney transplant patient: parathyroid allotransplantation. Thyroid (2005) 0.80
Importance of introduction of a psychological care unit in a liver transplantation unit. Transplant Proc (2010) 0.80
Plasma fibronectin values in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Clin Pathol (1988) 0.80
Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients. J Biol Response Mod (1986) 0.80
Spatial and temporal correlation between early nerve fiber growth and neuroepithelial cell death in the chick embryo retina. Anat Embryol (Berl) (1988) 0.79
Entamoeba histolytica: monoclonal antibody against the beta1 integrin-like molecule (140 kDa) inhibits cell adhesion to extracellular matrix components. Exp Parasitol (2001) 0.79
Incidence and survival rate of hepatic retransplantation in a series of 300 orthotopic liver transplants. Transplant Proc (2000) 0.79
Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization. Cytometry (1995) 0.79
Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites. Biochem Biophys Res Commun (2000) 0.79
Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas. J Immunol (1973) 0.78
Effect of oral administration of acetylsalicylic acid on haemostasis in the horse. Equine Vet J (1981) 0.78
Immunological studies of male homosexuals with the prodrome of the acquired immunodeficiency syndrome (AIDS). Adv Exp Med Biol (1983) 0.78
Remission of AIDS-associated psoriasis with zidovudine. Lancet (1987) 0.78
Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG. J Surg Res (1972) 0.78
Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci (1995) 0.77
Transgenic pig-to-baboon liver xenotransplantation: clinical, biochemical, and immunologic pattern of delayed acute vascular rejection. Transplant Proc (2002) 0.77
Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of disease. Ann N Y Acad Sci (1984) 0.77
Immunosuppressive effects of macrophage lysis. Surg Forum (1970) 0.77
Influence of administration of long-chain polyunsaturated fatty acids on process of histological recovery in liver cirrhosis produced by oral intake of thioacetamide. Dig Dis Sci (1996) 0.77
What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation? Transplant Proc (2012) 0.77
Nanoparticle-based assay for the detection of virgin argan oil adulteration and its rapid quality evaluation. Anal Bioanal Chem (2011) 0.77
Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon. Leukemia (1987) 0.77
HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice. Cell Mol Biol (Noisy-le-grand) (1995) 0.76
Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells. Int J Cancer (1974) 0.76
Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production. Cancer Res (1983) 0.76
Entamoeba histolytica: tyrosine kinase activity induced by fibronectin through the beta1-integrin-like molecule. Exp Parasitol (2000) 0.76
Subcellular distribution of the Entamoeba histolytica 140 kDa FN-binding molecule during host-parasite interaction. Parasitology (2006) 0.76
Construction and evaluation of ion selective electrodes for nitrate with a summing operational amplifier. Application to tobacco analysis. Talanta (2001) 0.75
Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine. Surgery (1974) 0.75
Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity. Ann N Y Acad Sci (1976) 0.75
[Monocytic leukemia, Shilling type, with cutaneous lesions]. Actas Dermosifiliogr (1976) 0.75
[Congenital dyserythropoiesis, type II (HEMPAS). Report of one case (author's transl)]. Sangre (Barc) (1976) 0.75
[Report of 5 cases of thalassemia in natives of the Salamanca region]. Sangre (Barc) (1971) 0.75
Complete and repeatable inactivation of HIV-1 viral particles in suspension using a photo-labeled non-nucleoside reverse transcriptase inhibitor. J Virol Methods (2013) 0.75
Neuraminidase and concanavalin A in the experimental immunotherapy of cancer. Johns Hopkins Med J Suppl (1974) 0.75
Response of malignant melanoma to plasma exchange, surgical debulking, and Corynebacterium parvum. Int J Artif Organs (1978) 0.75
The biosynthesis of cholesterol and other sterols by brain tissue. Distribution in subcellular fractions as a function of time after intracerebral injection into developing brain of (2- 14 C)mevalonic. J Neurochem (1972) 0.75
Neuraminidase treated cells and their role in cancer immunotherapy. Birth Defects Orig Artic Ser (1973) 0.75
Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase. J Surg Oncol (1972) 0.75
Modifying the immunogenicity of cell membrane antigens. Tumors and transplants. Am J Clin Pathol (1975) 0.75
Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells. Transplant Proc (1975) 0.75
Modified tumor cells in the immunotherapy of solid mammary tumors. Med Clin North Am (1976) 0.75
The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma. J Surg Oncol (1977) 0.75